Narcissus and Daffodil

204 J. Bastida and F. Viladomat
Fuganti, C. and Mazza, M. (1971a) Relative stereochemistry of protonation and hydroxylation
in the biosynthesis of lycorenine and haemanthidine from protocatechualdehyde. Journal
of the Chemical Society Chemical Communications, 1196–1197.
Fuganti, C. and Mazza, M. (1971b) Late intermediates in the biosynthesis of narciclasine.
Journal of the Chemical Society Chemical Communications, 1388–1389.
Fuganti, C. and Mazza, M. (1972a) The absolute configuration of narciclasine: A biosynthetic
approach. Journal of the Chemical Society Chemical Communications, 239.
Fuganti, C. and Mazza, M. (1972b) Stereochemistry of hydroxylation in the biosynthesis of
lycorine in Clivia miniata Regel. Journal of the Chemical Society Chemical Communications,
936–937.
Fuganti, C. and Mazza, M. (1973) Biosynthesis of Amaryllidaceae alkaloids. Stereochemistry
of hydrogen removal to the tertiary nitrogen atom in the biological conversion of
norpluviine into lycorenine. Journal of the Chemical Society Perkin Transactions I, 954–956.
Fuganti, C., Staunton, J. and Battersby, A.R. (1971) The biosynthesis of narciclasine. Journal
of the Chemical Society Chemical Communications, 1154–1155.
Fuganti, C., Ghiringhelli, D. and Grasselli, P. (1974a) Biosynthesis of narcissidine. Journal of
the Chemical Society Chemical Communications, 350–351.
Fuganti, C., Ghiringhelli, D. and Grasselli, P. (1974b) Further information on the origin of
the aromatic, C6-C1 unit of the amaryllidaceae alkaloids. Tetrahedron Letters, 2261–2264.
Fulton, B. and Benfield, P. (1996) Galanthamine. Drugs and Aging, 9, 60–65.
Furusawa, E. and Furusawa, S. (1986) Therapeutic potentials of pretazettine, standard
anticancer drugs, and combinations of subcutaneously implanted Lewis lung carcinoma.
Chemotherapy, 32, 521–529.
Furusawa, E. and Furusawa, S. (1988) Effect of pretazettine and Viva-Natural, a dietary
seaweed extract, on spontaneous AKR leukemia in comparison with standard drugs.
Oncology, 45, 180–186.
Furusawa, E., Furusawa, S., Morimoto, S. and Cutting, W. (1971) Therapeutic activity of
Narcissus alkaloid on Rauscher leukemia and comparison with standard drugs. Proceedings
of the Society for Experimental Biology and Medicine, 136, 1168–1173.
Furusawa, E., Suzuki, N., Ramanathan, S., Furusawa, S. and Cutting, W. (1972) Effect of
long-term administration of Narcissus alkaloids on Rauscher leukemia and combinations
with standard drugs. Proceedings of the Society for Experimental Biology and Medicine, 140,
1034–1040.
Furusawa, E., Suzuki, N., Tani, S., Furusawa, S., Ishioka, G.Y. and Motobu, J. (1973) Anticancer
activity of Narcissus extracts in mice. Proceedings of the Society for Experimental Biology
and Medicine, 143, 33–38.
Furusawa, E., Suzuki, N., Furusawa, S. and Lee J.Y.B. (1975) Combination chemotherapy
of Rauscher leukemia and ascites tumors by Narcissus alkaloids with standard drugs and
effect on cellular immunity. Proceedings of the Society for Experimental Biology and Medicine,
149, 771–778.
Furusawa, E., Furusawa, S., Tani, S., Irie, H., Kitamura, K. and Wildman, W.C. (1976a)
Isolation of pretazettine from Narcissus tazetta L. Chemical and Pharmaceutical Bulletin, 24,
336–338.
Furusawa, E., Furusawa, S., Lee, J.Y.B. and Patanavanich, S. (1976b) Therapeutic activity
of pretazettine, a Narcissus alkaloid on Rauscher leukemia: Comparison with tazettine and
streptonigrin. Proceedings of the Society for Experimental Biology and Medicine, 152, 186–191.
Furusawa, E., Furusawa, S., Lee, J.Y.B. and Patanavanich, S. (1978) Therapeutic activity of
pretazettine on Rauscher leukemia: Combination of antiviral activity and cellular protein
inhibition. Chemotherapy, 24, 259–266.
Furusawa, E., Lockwood, R.H., Furusawa, S., Lum, M.K.M. and Lee, J.Y.B. (1979)
Therapeutic activity of pretazettine, a Narcissus alkaloid, on spontaneous AKR leukemia.
Chemotherapy, 25, 308–315.